‘Topical Dermatological Product Development in the USA’ Workshop to Be Held on June 4, 2009 in East Brunswick, New Jersey, USA

Featuring US experts in topical dermatological drug development

PETALUMA, Calif., April 9 /PRNewswire/ — Dow Pharmaceutical Sciences, Inc. today announced that it will hold a 1-day workshop on “Topical Dermatological Product Development in the USA” June 4, 2009 at the Hilton East Brunswick, New Jersey.

This workshop will focus on the unique problems and issues confronted during development of topical dermatological drugs intended for the US market.

“Our line-up of dermatological experts for this workshop is exceptional,” said Gordon Dow, Founder and Chief Technical Officer at Dow Pharmaceutical Sciences. “Anyone considering development of a topical dermatological product should benefit from attending this focused workshop.”

The morning session will cover formulation and screening of topical products for regulatory, clinical and commercial success, CMC issues and pitfalls, and the role of project management in successful development programs.

The afternoon session will cover FDA safety concerns and non-clinical requirements, clinical endpoints and trial designs. The FDA perspective will be presented by the retired founding director of the FDA Dermatology Division, including strategies for successful FDA meetings.

A Q&A roundtable to include all speakers will conclude the program.

A reception from 5-7PM on June 3rd will be hosted by Dow Pharmaceutical Sciences, Inc.

See www.dowpharmsci.com for information on this exciting workshop.

    Contact:
    Vanlee Waters, Dow Pharmaceutical Sciences at 707.796.7239
    E-mail: vwaters@dowpharmsci.com

SOURCE Dow Pharmaceutical Sciences, Inc.